Prelude Therapeutics Insider Trades

PRLD

Track insider trading activity from Prelude Therapeutics executives and directors. See which insiders are buying and selling PRLD stock.

Trades Last 12 Months

PRLD Price

All Insider Trades for Prelude Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Morris Charles Q Chief Medical Officer
Holding Value $1.65M 450,000 shares
Last Trade
May 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.12M 450,000 shares
$4.70
$3.66
Holding Value $5.15M 1,407,000 shares
Last Trade
Apr 27, 2026 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$6.36M 1,407,000 shares
$4.52
$3.66
Holding Value $73.6M 20,105,994 shares
Last Trade
Apr 21, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$9.88M 2,137,651 shares
$4.62
$3.66
Bonita David P 10% owner
Holding Value $43.2M 11,808,945 shares
Last Trade
Apr 21, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$12.5M 2,815,315 shares
$4.44
$3.66
Holding Value $4.12M 1,126,126 shares
Last Trade
Apr 21, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5M 1,126,126 shares
$4.44
$3.66
Brusky Sean P. Chief Business Officer
Holding Value $366k 100,000 shares
Last Trade
Mar 05, 2026 Sale
$858k 275,000 shares
$3.12
$3.66
Holding Value $3.06M 837,000 shares
Last Trade
Feb 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.93M 837,000 shares
$2.30
$3.66
Combs Andrew Chief Chemistry Officer
Holding Value $842k 230,000 shares
Last Trade
Feb 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$529k 230,000 shares
$2.30
$3.66
Lim Bryant David Clo, Cfo, Corp Sec.
Holding Value $1.01M 275,000 shares
Last Trade
Feb 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$633k 275,000 shares
$2.30
$3.66
Scherle Peggy Chief Scientific Officer
Holding Value $842k 230,000 shares
Last Trade
Feb 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$529k 230,000 shares
$2.30
$3.66
Sandor Victor Director
Holding Value $444k 121,285 shares
Last Trade
Nov 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$169k 121,285 shares
$1.39
$3.66
Huang Jane President, CMO
Holding Value $68.6k 18,750 shares
Last Trade
Oct 04, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$13.8k 9,375 shares
$1.47
$3.66
Babler Martin Director
Holding Value $139k 38,000 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$39.5k 38,000 shares
$1.04
$3.66
Dier Mardi Director
Holding Value $139k 38,000 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$39.5k 38,000 shares
$1.04
$3.66
Friedman Paul A Director
Holding Value $139k 38,000 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$39.5k 38,000 shares
$1.04
$3.66
Chardonnet Laurent Chief Financial Officer
Holding Value $549k 150,000 shares
Last Trade
Mar 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$689k 150,000 shares
$4.59
$3.66
Holding Value $126k 34,300 shares
Last Trade
Jun 17, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$163k 34,300 shares
$4.74
$3.66
Morosini Deborah Evp, Chief Of Clinical Affairs
Holding Value $329k 90,000 shares
Last Trade
Feb 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$952k 90,000 shares
$10.58
$3.66
Mauro David J Chief Medical Officer
Holding Value $504k 137,610 shares
Last Trade
Oct 05, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$451k 15,000 shares
$30.04
$3.66
Pierce Christopher EVP And Chief Of Business Oper
Holding Value $761k 207,796 shares
Last Trade
Sep 02, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$657k 17,000 shares
$38.65
$3.66

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up